Vigilant Biosciences
AI-powered oral cancer screening assessment tool for early detection
- Sector
- Medtech
- Headquarters
- FORT LAUDERDALE, FL
- Founded
- 2011
- Latest Form D
- $450K, Nov 2019
- Total capital
- $13.5M
- Federal grants
- $439K
- 3 awards · 2016–2017
- Rank in peer group#453 of 542
- Private capital raised
- $13.1M
- 5 Form D · last Nov 2019
- 84 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 10 pending · first 2021
- Rank in peer group#106 of 542
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$450K
- Private capital raisedForm D · SEC · 4th filing$2.4M
- Federal grantHealth and Human S · Phase I · Optical imaging of a CD44-based oral-rinse with fluorescent detection to visualize oral cancer$28K
- Federal grantHealth and Human S · Phase I · Optical imaging of a CD based oral rinse with fluorescent detection to visualize oral cancer$219K
- Federal grantHealth and Human S · Phase I · Optical imaging of a CD44-based oral-rinse with fluorescent detection to visualize oral cancer$192K
- Private capital raisedForm D · SEC · 3rd filing$3.2M
- Private capital raisedForm D · SEC · 2nd filing$5M
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#106 · top 20%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- ERIC M. STONEDirectorNamed in SEC Form D filings
- Jeffrey H. J. GoodmanDirectorNamed in SEC Form D filings
- Jonathan T. LordDirectorNamed in SEC Form D filings
- Linda NiessenDirectorNamed in SEC Form D filings
- Matthew H. J. KimExecutive Officer, DirectorNamed in SEC Form D filings
- Robert HamiltonExecutive OfficerNamed in SEC Form D filings
Show all 9 people
- Stuart HeapExecutive Officer, DirectorNamed in SEC Form D filings
- Timothy H. J. BarabeDirectorNamed in SEC Form D filings
- William BrodieExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 11- PendingMethods and Compositions for Oral Cancer RiskUSPTOApplication 19122111
- GrantedDevice For Early Detection Of Disease StatesUSPTOUS 11,150,246
- PendingImaging Device And Method For Detection Of DiseaseUSPTOApplication 15564879
Show all 11 patent records
- Methods and Compositions for Oral Cancer RiskOct 23, 2025 · Application 19122111Pending
- Device For Early Detection Of Disease StatesOct 19, 2021 · US 11,150,246Granted
- Imaging Device And Method For Detection Of DiseaseJul 5, 2018 · Application 15564879Pending
- Device For Detection Of Disease States And Applications Of SameJun 22, 2017 · Application 15127156Pending
- Device For Methods Of Detecting CancerApplication 62810551Pending
- Methods And Compositions For Oral Cancer RiskApplication PCTUS2023035308Pending
- Imaging Device And Method For Detection Of DiseaseApplication PCTUS2016026223Pending
- Device For Early Detection Of Disease StatesApplication PCTUS2015049584Pending
- Imaging Device And Method For Detection Of DiseasesApplication 62143632Pending
- Device For Detection Of Disease States And Applications Of SameApplication PCTUS2015021532Pending
- Device For Early Detection Of Disease StatesApplication 61955629Pending
Related companies, and why
- MASSTECH, INC.Similar federal contract value in Medtech · null in contracts
- WICKED SHEETS, LLCSimilar federal contract value in Medtech · null in contracts
- G5 BIOLOGICAL INNOVATIONS LLCSimilar federal contract value in Medtech · null in contracts
- HYPERMELT, LLCSimilar federal contract value in Medtech · null in contracts
- CAROLINA INSTRUMENTS, INC.Similar federal contract value in Medtech · null in contracts
- REGENDODENT, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .